Silmitasertib (CX-4945) is a potent and selective orally bioavailable small molecule inhibitor of Casein kinase II (CK2). The antiproliferative activity of CX-4945 against cancer cells correlated with expression levels of the CK2α catalytic subunit. CX-4945 caused cell-cycle arrest and selectively induced apoptosis in cancer cells relative to normal cells.
仅供研究使用。 我们不向患者出售。
名称 | CX-4945(Silmitasertib) |
---|---|
Iupac 化学名称 | 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid |
同义词 | CX-4945;Silmitasertib;CX4945;CX 4945 |
英文同义词 | CX-4945;Silmitasertib;CX4945;CX 4945 |
分子式 | C19H12ClN3O2 |
分子量 | 349.77 |
Smile | ClC=1C=C(C=CC1)NC1=NC2=C(C3=CN=CC=C13)C=CC(=C2)C(=O)O |
InChiKey | MUOKSQABCJCOPU-UHFFFAOYSA-N |
InChi | InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25) |
Cas号 | 1009820-21-6 |
相关CAS号 |
包装 | 价格 | 库存 | 纯度 | 备货期 |
---|---|---|---|---|
大货 | 询价 | 询价 | 询价 |